Is glycoprotein YKL40 a new marker for joint disorders?

Joint Bone Spine

Volumn 68, Issue 6, 2001, Pages 454-456

  Vignon, Érick ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; PROTEIN YKL 40; UNCLASSIFIED DRUG;

ARTHROPATHY; EDITORIAL; HUMAN; HUMAN TISSUE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TISSUE SPECIFICITY;

EID: 0035670317     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(01)00307-4     Document Type: Editorial

References (21)

1. Recommendations for the registration of drugs used in the treatment of osteoarthritis: An update on biochemical markers
2. Le chondrex, marqueur du cartilage articulaire et de la fibrose hépatique
3. Human synovial cells secrete a 39 kda protein similar to a bovine mammary protein expressed during non-lactating period
4. Identification of proteins secreted by human osteoblastic cells in culture
5. Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in situ hybridization
6. Human cartilage gp-39, a major secretory products of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family
7. Purification of guinea pig YKL 40 and modulation of its secretion by cultured articular chondrocytes
8. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family
9. Human cartilage gp-39+, CD16+ monocytes in peripheral blood and synovium
10. The distribution of YKL 40 in osteoarthritic and normal human articular cartilage
11. Isolation and characterization of a novel 39 kilodalton protein from bovine mammary secretions collected during the non lactating period
12. YKL 40, a matrix protein of specific granules in neutrophils, is elevated in patients with community-acquired pneumonia requiring hospitalization
13. Serum YKL 40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL 40 in patients with osteoarthritis or trauma of the knee joint
14. Chondrex: A new marker of joint disease
15. A new biochemical marker for joint injury. Analysis of YKL 40 in serum and synovial fluid
16. YKL 40 in giant cells and macrophages from patients with giant cell arteritis
17. Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions
18. Serum YKL 40 concentrations in patients with rheumatoid arthritis: Relation to disease activity
19. The relationship between serum levels of YKL 40 and disease progression in patients with early rheumatoid arthritis
20. Cross-sectional evaluation of biochemical markers of bone, cartilage and synovial tissue metabolism in patients with knee osteoarthritis
21. Serum levels of YKL 40 and C reactive protein in patient with hip osteoarthritis and healthy subjects: A cross sectional study